Reversair ODT 5 mg (Dispersible Tablet)

Unit Price: ৳ 9.00 (3 x 10: ৳ 270.00)
Strip Price: ৳ 90.00

Medicine Details

Indications

  • Prophylaxis and chronic treatment of asthma
  • Acute prevention of Exercise-Induced Bronchoconstriction (EIB)
  • Relief of symptoms of Allergic Rhinitis (AR): Seasonal & Perennial Allergic Rhinitis

Pharmacology

  • Selective and orally active leukotriene receptor antagonist
  • Inhibits the cysteinyl leukotriene receptor (CysLT1)
  • Correlated with the pathophysiology of asthma & allergic rhinitis
  • Contributes to the signs and symptoms of asthma

Dosage & Administration

  • Dosage for adults and adolescents 15 years of age and older: Montelukast 10 mg tablet once daily
  • Dosage for pediatric patients 6 to 14 years of age: Montelukast 5 mg tablet once daily
  • Dosage for pediatric patients 2 years to 5 years of age: Montelukast 4 mg tablet once daily
  • Dosage for pediatric patients 6 months to 5 years of age: Montelukast 4 mg oral granules once daily

Interaction

  • No clinically important effects on the pharmacokinetics of certain drugs
  • May be used concomitantly with a wide range of commonly prescribed drugs
  • Phenobarbital decreased the AUC of Reversair ODT by approximately 40%

Contraindications

  • Hypersensitivity to any component of this product

Side Effects

  • Common: Diarrhoea, fever, gastrointestinal discomfort, headache, nausea, vomiting, skin reactions, upper respiratory tract infection
  • Uncommon: Akathisia, anxiety, arthralgia, asthenia, abnormal behavior, depression, dizziness, drowsiness, dry mouth, haemorrhage, irritability, malaise, muscle complaints, oedema, seizure, abnormal sensation, sleep disorders
  • Rare: Angioedema, concentration impaired, disorientation, eosinophilic granulomatosis with polyangiitis, erythema nodosum, hallucination, hepatic disorders, memory loss, palpitations, pulmonary eosinophilia, suicidal tendencies, tremor

Pregnancy & Lactation

  • Crosses the placenta following oral dosing in rats and rabbits
  • Should be used during pregnancy only if clearly needed
  • Caution should be exercised when given to a nursing mother

Precautions & Warnings

  • Not indicated for use in the reversal of bronchospasm in acute asthma attacks
  • Patients should have appropriate rescue medication available
  • Should not be used as monotherapy for the treatment and management of exercise induced bronchospasm
  • Patients with known aspirin sensitivity should continue avoidance of aspirin or non-steroidal anti-inflammatory agents while taking Reversair ODT

Overdose Effects

  • No adverse experiences in the majority of reports
  • Most frequently occurring adverse experiences include abdominal pain, somnolence, thirst, headache, vomiting, and psychomotor hyperactivity

Therapeutic Class

Leukotriene receptor antagonists

Storage Conditions

Store in cool & dry place below 30°C, protect from light & moisture

Chemical Structure

  • Molecular Formula: C35H36ClNO3S
  • Chemical Structure Image: Montelukast Sodium Chemical Structure

Common Questions about Reversair ODT 5 mg Tablet

  • What is Reversair ODT 5 mg DT?
  • What is Reversair ODT 5 mg DT used for?
  • How soon can the effect of Reversair ODT 5 mg DT be observed?
  • How long does the effect of Reversair ODT 5 mg DT last?
  • Should I use Reversair ODT 5 mg DT empty stomach?
  • What if I miss a dose of Reversair ODT 5 mg DT?
  • Are there any pregnancy warnings for Reversair ODT 5 mg DT?
  • General Instructions

Related Brands